Salona Global Medical Device Corporation
Symbol: SGMD.V
TSX
0.22
CADDzisiejsza cena rynkowa
-15.8062
Wskaźnik P/E
0.2483
Wskaźnik PEG
17.24M
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Salona Global Medical Device Corporation (SGMD-V) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 8.1 | 7.6 | 9.2 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.net-receivables | 0 | 7 | 0.1 | 0.1 | |||||||||
balance-sheet.row.inventory | 0 | 5 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 20 | 13.1 | 9.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5.4 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 0 | 9.8 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 6.9 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.8 | 0 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.5 | 0 | 0 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 22.6 | 0 | 0 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.account-payables | 0 | 2.9 | 0.5 | 0.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 5.9 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 4.6 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 13.6 | 6 | 0 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.4 | 0 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 4.2 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 29.5 | 6.5 | 0.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 38.5 | 31.1 | 31.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -33.4 | -29 | -26.9 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1 | 0.9 | 1.4 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7 | 3.6 | 3.4 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.total-debt | 0 | 10.5 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 0 | 2.5 | -7.1 | -8.3 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -4.4 | -2.7 | -1.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 1.2 | 0.2 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -0.2 | 1.3 | 1.3 | ||||||||
cash-flows.row.account-receivables | 0 | -2.1 | -2.1 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0.2 | 0.2 | 0 | ||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-working-capital | 0 | 1.6 | 3.1 | 0 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1.1 | -0.5 | 0.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.acquisitions-net | 0 | -5.1 | -5.1 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.4 | -0.9 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.4 | 0 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 5.1 | 0 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4.6 | 0.1 | -0.9 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.5 | -2.5 | 0 | ||||||||
cash-flows.row.common-stock-issued | 0 | 4.3 | 4.3 | 0 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 2.2 | 3.7 | 0 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3.9 | 5.4 | 0 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.1 | -0.4 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | 0 | -4.4 | 4.2 | -1 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 8.1 | 12.5 | 8.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 12.5 | 8.3 | 9.3 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -3.7 | -1 | -0.1 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.free-cash-flow | 0 | -3.8 | -1 | -0.1 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 18.3 | 0 | 0.4 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 12.4 | 12.4 | 0.4 | ||||||||
income-statement-row.row.gross-profit | 0 | 6 | -12.4 | 0 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.operating-expenses | 0 | 6.6 | 1 | 1.7 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 18.9 | 1 | 2.1 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | -4.5 | -1 | -1.7 | ||||||||
income-statement-row.row.income-before-tax | 0 | -4.5 | -2.7 | -1.8 | ||||||||
income-statement-row.row.income-tax-expense | 0 | -0.1 | -0.1 | 0.6 | ||||||||
income-statement-row.row.net-income | 0 | -4.4 | -2.7 | -2.3 |
Często zadawane pytania
Ile wynosi Salona Global Medical Device Corporation (SGMD.V) aktywów ogółem?
Salona Global Medical Device Corporation (SGMD.V) całkowite aktywa to 42681612.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.357.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -0.015.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -0.023.
Jaki jest całkowity przychód firmy?
Całkowity przychód to -0.080.
Co to jest Salona Global Medical Device Corporation (SGMD.V) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -4372019.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 10533056.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 6570013.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.